Patients with T2DM are more likely to undergo some surgical procedures than those without the condition [3], partly due to vascular complications that increase their need for surgery
La obesidad puede tener efectos negativos de largo alcance sobre la salud y la calidad de vida, aumentando el riesgo de enfermedades cardiovasculares
One GLP-1RA, liraglutide, has been approved to treat obesity, and another, semaglutide, is in clinical trials

Hydrogenated polyisobutene, Diisostearyl malate, Petrolatum, Microcrystalline wax, Ethylhexyl Salicylate Ethylhexyl Triazone, Diethylhexyl Butamido Triazone, Zinc Oxide, C12-15 Alkyl Benzoate, Isostearic Acid, Polyhydroxystearic acid, Butyrospermum parkii butter, Avocado butter, Murumuru seed butter, Olive oil, Caprylic/capric triglyceride, Bis-behenyl/isostearyl/phytosteryl dimer dilinoleyl dimer dilinoleate, Jojoba oil, Argan oil, Sorbitan Olivate, Diisostearyl malate, Castor oil, Ethylene/propylene/styrene copolymer, Euphorbia Cerifera wax, Beeswax, Squalane, Punica granatum seed oil, Glycerin, Butylene glycol, Ascorbyl palmitate, Ceramide complex, Lauryl Laurate, Silica dimethyl silylate, Tocopheryl Acetate, Olea Europaea Fruit Extract, Olea Europaea Fruit Oil, Olea Europaea Leaf Extract, Oligo peptide-1 Butylene/ethylene/styrene copolymer, Caprylyl methicone, Hyaluronic acid